H. Ericsson
Department of Experimental Medicine
AstraZeneca R&D Mölndal
Mölndal
Sweden
Name/email consistency: high
- Pharmacokinetics and metabolism of tesaglitazar, a novel dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist, after a single oral and intravenous dose in humans. Ericsson, H., Hamrén, B., Bergstrand, S., Elebring, M., Fryklund, L., Heijer, M., Ohman, K.P. Drug Metab. Dispos. (2004)
- Enantioselective pharmacokinetics of the enantiomers of clevidipine following intravenous infusion of the racemate in essential hypertensive patients. Ericsson, H., Schwieler, J., Lindmark, B.O., Löfdahl, P., Thulin, T., Regårdh, C.G. Chirality (2001)
- Pharmacokinetics and arteriovenous differences in clevidipine concentration following a short- and a long-term intravenous infusion in healthy volunteers. Ericsson, H., Bredberg, U., Eriksson, U., Jolin-Mellgård, A., Nordlander, M., Regårdh, C.G. Anesthesiology (2000)
